Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

35.18 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

29 30 Next >

Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug ↗

June 04, 2024

Viking Therapeutics stock falls despite seemingly positive test results for a drug that treats a serious liver disease.

Via Investor's Business Daily

What's Going On With Viking Therapeutics Stock On Tuesday? ↗

June 04, 2024

Viking Therapeutics reports promising 52-week data from its Phase 2b VOYAGE study on VK2809 for NASH.

Via Benzinga

The 3 Most Undervalued Biotech Stocks to Buy in June 2024 ↗

June 04, 2024

https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 03, 2024

Via Benzinga

1 Disruptive Biotech Stock to Buy Now, and 1 to Consider ↗

June 03, 2024

Both of these companies could soon set the standard in their fields.

Via The Motley Fool

Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years ↗

May 31, 2024

Via Benzinga

Market Whales and Their Recent Bets on VKTX Options ↗

May 28, 2024

Via Benzinga

Where Will Viking Therapeutics Be in 5 Years? ↗

May 25, 2024

Could Viking Therapeutics become a big player in the GLP-1 drug market?

Via The Motley Fool

The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy. ↗

June 03, 2024

There's probably a big enough pie here for everyone to get a slice.

Via The Motley Fool

Unearthing Unknown Stocks: 3 Picks That Could Be the Next Big Thing ↗

May 31, 2024

Sometimes the next big thing stocks to buy and hold are flying well under the radar. Here are three to consider.

Via InvestorPlace

3 Underappreciated Stocks with Triple-Digit Upside: May 2024 ↗

May 31, 2024

There are plenty of underappreciated stocks on the market. In fact, here are three you may want to consider buying and holding today.

Via InvestorPlace

If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names ↗

May 29, 2024

Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.

Via InvestorPlace

If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today ↗

May 26, 2024

What would a $100 investment in Viking Therapeutics back in 2022 be worth today? Prepare to be surprised.

Via The Motley Fool

Smart Money Is Betting Big In VKTX Options ↗

May 17, 2024

Via Benzinga

Is Viking Therapeutics Stock a Buy? ↗

May 17, 2024

The stock could have room to soar higher if VK2735 obtains approval from regulators.

Via The Motley Fool

Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today ↗

May 15, 2024

Via Benzinga

3 Biotech Stocks That Could Be Millionaire-Makers: May Edition ↗

May 25, 2024

Investors should take a close look at these biotech stocks as they position themselves to provide high returns.

Via InvestorPlace

2 Stocks That Could 10x by 2035 ↗

May 24, 2024

These stocks are very promising, but it's important to consider the downside, too.

Via The Motley Fool

Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound ↗

May 23, 2024

Discover three top Nasdaq stocks to buy. Learn about these investment opportunities and why they’re worth your attention.

Via InvestorPlace

Is It Too Late to Buy Viking Therapeutics Stock? ↗

May 22, 2024

This rising star probably won't burn out soon.

Via The Motley Fool

EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic ↗

May 21, 2024

Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and call it a day."

Via Benzinga

Topics ETFs

How Is The Market Feeling About Viking Therapeutics? ↗

May 14, 2024

Via Benzinga

3 Growth Stocks That Could Be Millionaire-Makers: May Edition ↗

May 21, 2024

Investors wanting to get rich should consider a long-term holding in these stocks, each of which has risen exponentially in the last year.

Via InvestorPlace

Wall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for May 2024 ↗

May 20, 2024

Consider following the recommendations of analysts and buy these small but mighty companies whose stocks are rising.

Via InvestorPlace

3 Monster Stocks in the Making You Can Buy Right Now ↗

May 18, 2024

These stocks might not be small for too much longer.

Via The Motley Fool

Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next? ↗

May 17, 2024

Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.

Via InvestorPlace

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

May 17, 2024

The Benzinga Stock Whisper highlights five stocks weekly that are seeing increased interest from readers.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

May 17, 2024

Via Benzinga

Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗

May 17, 2024

With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.

Via InvestorPlace

Tiny but Mighty: 3 Small-Cap Stocks Crushing the Russell 2000 ↗

May 16, 2024

Top small-cap stocks to buy Viking Therapeutics, Celsius and Hippo make waves in the weight loss, energy drink, and insurance tech sectors.

Via InvestorPlace

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

All News about Viking Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today